Ledger.Open graph →
SEC Form D · filed September 30, 2024

Mid-Atlantic BioTherapeutics, Inc

Offering
$5.0M
Sold
—
Exemption
Rule 506(c)
Industry
Biotechnology
Location
DOYLESTOWN, PA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (15)

David Horn · Doylestown, PAExec · DirectorJean Pierre Gagnon · Doylestown, PADirectorDavid Jobes · Doylestown, PAExec · DirectorMichael Goldblatt · Doylestown, PADirectorAndrew Katz · New York, NYDirectorKurt Brumme · Boston, MAExec · DirectorDavid Ament · Boston, MADirectorZach Sadek · Boston, MAExec · DirectorJulian Chick · Doylestown, PADirectorDil P. Dhungyel · Fort worth, TXDirectorTika P. Dhungyel · Fort Worth, TXExec · DirectorMadhav D. Ghimire · Fort Worth, TXExec · DirectorJulian Chick · Doylestown, PADirectorMichael Goldblatt · Doylestown, PADirectorAndrew Katz · White Plains, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗